Correlation Between AN2 Therapeutics and Marker Therapeutics
Can any of the company-specific risk be diversified away by investing in both AN2 Therapeutics and Marker Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AN2 Therapeutics and Marker Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AN2 Therapeutics and Marker Therapeutics, you can compare the effects of market volatilities on AN2 Therapeutics and Marker Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AN2 Therapeutics with a short position of Marker Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of AN2 Therapeutics and Marker Therapeutics.
Diversification Opportunities for AN2 Therapeutics and Marker Therapeutics
0.23 | Correlation Coefficient |
Modest diversification
The 3 months correlation between AN2 and Marker is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding AN2 Therapeutics and Marker Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Marker Therapeutics and AN2 Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AN2 Therapeutics are associated (or correlated) with Marker Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Marker Therapeutics has no effect on the direction of AN2 Therapeutics i.e., AN2 Therapeutics and Marker Therapeutics go up and down completely randomly.
Pair Corralation between AN2 Therapeutics and Marker Therapeutics
Given the investment horizon of 90 days AN2 Therapeutics is expected to under-perform the Marker Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, AN2 Therapeutics is 1.04 times less risky than Marker Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Marker Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 347.00 in Marker Therapeutics on September 12, 2024 and sell it today you would earn a total of 51.00 from holding Marker Therapeutics or generate 14.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
AN2 Therapeutics vs. Marker Therapeutics
Performance |
| Timeline |
| AN2 Therapeutics |
| Marker Therapeutics |
AN2 Therapeutics and Marker Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AN2 Therapeutics and Marker Therapeutics
The main advantage of trading using opposite AN2 Therapeutics and Marker Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AN2 Therapeutics position performs unexpectedly, Marker Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Marker Therapeutics will offset losses from the drop in Marker Therapeutics' long position.| AN2 Therapeutics vs. Equillium | AN2 Therapeutics vs. DiaMedica Therapeutics | AN2 Therapeutics vs. Valneva SE ADR | AN2 Therapeutics vs. Vivani Medical |
| Marker Therapeutics vs. Lumos Pharma | Marker Therapeutics vs. Exicure | Marker Therapeutics vs. Protagenic Therapeutics | Marker Therapeutics vs. Pmv Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stocks Directory Find actively traded stocks across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |